Yi-Hua Zhou

Prof. Dr. Yi-Hua Zhou

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2020 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Closed access
HZHong Zhao
Hong Zhao
XZXiaoying Zhou
Xiaoying Zhou
YZYi-Hua Zhou
Yi-Hua Zhou
Vaccination against hepatitis B is the most effective strategy to control HBV infection. The first licensed hepatitis B vaccine was developed by the purification of hepatitis B surface antigen (HBsAg) from plasma of asymptomatic HBsAg carriers. Then, the recombinant DNA technology enabled the development of recombinant hepatitis B vaccine. A series of three doses vaccine can elicit long-term protection more than 30 y. Concurrent use of hepatitis B immunoglobulin and hepatitis B vaccine has substantially reduced the mother-to-child transmission of HBV, nearly zero infection in children of carrier mother with negative hepatitis B e antigen (HBeAg) and 5–10% infection in children of HBeAg-positive mothers. By the end of 2018, 189 countries adopted universal hepatitis B vaccination program, which has dramatically reduced the global prevalence of HBsAg in children <5 y of age, from 4.7% in the prevaccine era to 1.3% in 2015. However, the implementation of universal hepatitis B vaccination in some regions is suboptimal and timely birth dose vaccine is not routinely administered in more than half of newborn infants. Optimal worldwide universal hepatitis B vaccination requires more efforts to overcome the social and economic challenges.

12 October 2021 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
WXWenfang Xiong
Wenfang Xiong
KSKuo-Yang Sun
Kuo-Yang Sun
YZYan Zhu
Yan Zhu
XZXiaoqi Zhang
Xiaoqi Zhang
YZYi-Hua Zhou
Yi-Hua Zhou
XZXiaoping Zou
Xiaoping Zou
Metformin, traditionally regarded as a hypoglycemic drug, has been studied in other various fields including inflammation. The specific mechanism of metformin’s effect on immune cells remains unclear. Herein, it is verified that LPS-induced macrophages are characterized by enhanced endogenous fatty acid synthesis and the inhibition of fatty acid synthase (FASN) downregulates proinflammatory responses. We further show that metformin could suppress such elevation of FASN as well as proinflammatory activation in macrophages. In vivo, metformin treatment ameliorates dextran sulfate sodium (DSS)-induced colitis through impairing proinflammatory activation of colonic lamina propria mononuclear cells (LPMCs). The reduction of FASN by metformin hinders Akt palmitoylation, which further disturbs Akt membrane attachment and its phosphorylation. Metformin-mediated suppression of FASN/Akt pathway and its downstream MAPK signaling contributes to its anti-inflammatory role in macrophages. From the perspective of immunometabolism, our work points towards metformin utilization as an effective and potential intervention against macrophages-involved inflammatory diseases.

3 February 2022 in Hepatology International
Verified
Journal Article
Closed access
PDF file
MKManoj Kumar
Manoj Kumar
ZAZaigham Abbas
Zaigham Abbas
MAMilad Azami
Milad Azami
MBMaria Belopolskaya
Maria Belopolskaya
ADA. K. Dokmeci
A. K. Dokmeci
YZYi-Hua Zhou
Yi-Hua Zhou

1 June 2020 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Closed access
PDF file
CWChen Wang
Chen Wang
YZYi-Hua Zhou
Yi-Hua Zhou
HYHuixia Yang
Huixia Yang
LPLiona C. Poon
Liona C. Poon

28 November 2017 in Journal of Viral Hepatitis
Verified
Journal Article
Closed access
PDF file
YHY. Hu
Y. Hu
CXC. Xu
C. Xu
BXB. Xu
B. Xu
LHL. Hu
L. Hu
QLQ. Liu
Q. Liu
YZYi-Hua Zhou
Yi-Hua Zhou

16 March 2020 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
YPYuzhu Peng
Yuzhu Peng
YZYi-Hua Zhou
Yi-Hua Zhou